Search

everythinglearnresearchcommunity

for

Search:↓

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

The study found that certain mutations in the vitamin D receptor can cause rickets and potentially affect hair growth.

PAON shows skin patterns due to genetic mosaicism.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Biotinidase deficiency can cause vision and walking problems in children and can improve with biotin treatment.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

A rare pituitary tumor in an 18-year-old male caused hormonal issues and vision loss, requiring surgery and further treatment.

DNA virus-induced tumors have consistent isozyme profiles, unlike other tumor types.

Some hair proteins are specific to hair, while others are also found in skin cells.

Light therapy may improve eye conditions by stimulating cell activity and increasing oxygen availability.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

PDGF isoforms can promote and sustain hair growth.

AP-1 controls tumor cell type by affecting key signaling pathways.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

An elderly man with skin amyloidosis and abnormal blood proteins was monitored without finding widespread disease after 18 months.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

Genetic testing for EGFR mutations is crucial in similar cases.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

MT-DADMe-ImmA can selectively kill head and neck cancer cells without harming normal cells.

Acitretin moderately improved skin and eye issues but not hair loss or light sensitivity in a 3-year-old with IFAP syndrome.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Bortezomib chemotherapy can cause temporary skin rashes.

A genetic defect in vitamin D receptors causes severe rickets and hair loss in children, but some heal as they age.

Child with rickets improved with a specific vitamin D therapy, but alopecia did not change.

Polyomavirus A2 infection in newborn mice caused hair follicle tumors.